Subscribe
Menu
Login
Login
Subscribe
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
March 2024
View This Issue
Archives
Features
Quarterly Magazine
Current Issue
Spring 2024
View This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell Biology
Community
Drug Development
Environment
Evolution
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
TS University
Scientific Services
Brush Up Summaries
Technique Talks
Journal Club
TS SciComm
Multimedia
Crossword Puzzles
eBooks
Infographics
Podcasts
Research Products Blog
Research Articles
Science Snapshot
Slideshows
Videos
Words for Nerds
Webinars
ADVERTISEMENT
404
Not Found
Is this what you were looking for?
tag disease medicine pharma business
Biotech Buys Autoimmune Firm for $7B
Kerry Grens
| Jul 16, 2015
| 1 min read
Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.
The Profits of Nonprofit
Megan Scudellari
| Jan 1, 2011
| 7 min read
The surprising results when drug development and altruism collide
Female Frontrunners
Jef Akst
| Feb 1, 2012
| 7 min read
How to successfully surmount the challenges women face in becoming biotech industry leaders
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams
| Nov 11, 2020
| 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Novartis’s $9.7 Billion Purchase Includes Novel PCSK9 Inhibitor
Emily Makowski
| Nov 25, 2019
| 2 min read
The pharmaceutical firm is buying The Medicines Company, which recently devoted its efforts into developing the cholesterol-lowering medication.
The Growth of Iowa Biotech
Jenny Rood
| Aug 1, 2016
| 7 min read
The state’s industry draws inspiration from medicine as well as agriculture.
Start It Up
Dan Cossins
| Apr 1, 2013
| 8 min read
Young researchers who left the academic path to transform their bright ideas into thriving companies discuss their experiences, and how you can launch your own business.
Make Mine Rare
Megan Scudellari
| Aug 1, 2011
| 7 min read
With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.
FDA Approves New Cystic Fibrosis Drug
Shawna Williams
| Oct 24, 2019
| 1 min read
The treatment, Trikafta, increases lung function in most patients with the disease—but comes with a hefty price tag.
Defying Dogma: Decentralized Translation in Neurons
Danielle Gerhard, PhD
| Sep 8, 2023
| 10+ min read
To understand how memories are formed and maintained, neuroscientists travel far beyond the cell body in search of answers.
Run a Search
ADVERTISEMENT